Low dose vs standard dose of antipsychotics for relapse prevention in schizophrenia: Meta-analysis

Keyphrases

• Antipsychotics 100%
• Schizophrenia 100%
• Meta-analysis 100%
• Relapse Prevention 100%
• Defined Daily Dose 100%
• Ultra-low Dose 75%
• Hospitalization 50%
• Treatment Failure 50%
• Antipsychotic Treatment 50%
• No Significant Difference 25%
• Dropout 25%
• Schizophrenia Treatment 25%
• Relapse Risk 25%
• Cochrane Central Register of Controlled Trials 25%
• MEDLINE 25%
• Data Synthesis 25%
• Embase 25%
• World Health Organization 25%
• Antipsychotic Dose 25%
• Data Extraction 25%
• Patient Dropouts 25%
• Double-blind Trial 25%
• Clinical Relapse 25%
• Clinical Trial Data 25%
• Follow-up Duration 25%
• Statistically Significant Difference 25%
• Antipsychotic Drugs 25%
• Trend Level 25%
• Low-intensity Interventions 25%
• Acute Phase Treatment 25%

Medicine and Dentistry

• Meta-Analysis 100%
• Low Drug Dose 100%
• Relapse Prevention 100%
• Schizophrenia 100%
• Antipsychotic 50%
• Side Effect 25%
• Randomized Controlled Trial 12%
• Clinical Trial 12%
• Treatment of Schizophrenia 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Schizophrenia 100%
• Antipsychotic 80%
• Defined Daily Dose 80%
• Side Effect 40%
• Clinical Trial 20%
• Randomized Controlled Trial 20%
• Maintenance Dose 20%